HI
AVXL icon

Harbour Investments’s Anavex Life Sciences AVXL Stock Holding History

Harbour Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2K Hold
850
– – ﹤0.01% 3986
2026
Q1 		$2.61K Sell
850
-35
-4% -$152 ﹤0.01% 3826
2025
Q4 		$3.15K Hold
885
– – ﹤0.01% 3181
2025
Q3 		$7.88K Hold
885
– – ﹤0.01% 2795
2025
Q2 		$8.16K Hold
885
– – ﹤0.01% 2663
2025
Q1 		$7.59K Buy
885
+50
+6% +$472 ﹤0.01% 2648
2024
Q4 		$8.97K Hold
835
– – ﹤0.01% 2498
2024
Q3 		$4.74K Hold
835
– – ﹤0.01% 2646
2024
Q2 		$3.52K Sell
835
-1,000
-54% -$4.04K ﹤0.01% 2636
2024
Q1 		$9.34K Buy
1,835
+1,000
+120% +$5.63K ﹤0.01% 2248
2023
Q4 		$7.77K Buy
835
+335
+67% +$2.31K ﹤0.01% 2246
2023
Q3 		$3.27K Hold
500
– – ﹤0.01% 2414
2023
Q2 		$4.07K Hold
500
– – ﹤0.01% 2346
2023
Q1 		$4.29K Hold
500
– – ﹤0.01% 2326
2022
Q4 		$4.63K Buy
500
+300
+150% +$3.21K ﹤0.01% 2247
2022
Q3 		$2K Hold
200
– – ﹤0.01% 2397
2022
Q2 		$2K Buy
+200
New +$1.89K ﹤0.01% 2397
2021
Q4 		$3K Sell
200
-100
-33% -$1.9K ﹤0.01% 2295
2021
Q3 		$5K Buy
+300
New +$5.97K ﹤0.01% 2960
2021
Q2 		– Sell
-3,000
Closed -$45K – 3757
2021
Q1 		$45K Buy
+3,000
New +$32.8K ﹤0.01% 1752

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Harbour Investments's AVXL Position: Q2 2026 in Review

Harbour Investments held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 850 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3986.

Harbour Investments first reported a position in AVXL in Q1 2021 and has held it in 20 quarters since. The position peaked at $45K in Q1 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Harbour Investments held 850 shares of Anavex Life Sciences worth $2.2K as of Q2 2026.
  • Harbour Investments left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3986 holding.
  • Harbour Investments first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Anavex Life Sciences position peaked at $45K in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.